{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:09:13Z","timestamp":1781827753139,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T00:00:00Z","timestamp":1498694400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s40264-017-0560-z","type":"journal-article","created":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T12:55:41Z","timestamp":1498740941000},"page":"1141-1146","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Signal of Miscarriage with Aripiprazole: A Disproportionality Analysis of the Japanese Adverse Drug Event Report Database"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9086-6999","authenticated-orcid":false,"given":"Takamasa","family":"Sakai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiko","family":"Ohtsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiyo","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouichi","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,29]]},"reference":[{"key":"560_CR1","first-page":"e380","volume":"19","author":"GE Robinson","year":"2012","unstructured":"Robinson GE. Treatment of schizophrenia in pregnancy and postpartum. J Popul Ther Clin Pharmacol. 2012;19:e380\u20136.","journal-title":"J Popul Ther Clin Pharmacol"},{"key":"560_CR2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/JCP.0b013e318295fe12","volume":"33","author":"F Habermann","year":"2013","unstructured":"Habermann F, Fritzsche J, Fuhlbruck F, Wacker E, Allignol A, Weber-Schoendorfer C, Meister R, Schaefer C. Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort study. J Clin Psychopharmacol. 2013;33:453\u201362.","journal-title":"J Clin Psychopharmacol"},{"key":"560_CR3","doi-asserted-by":"crossref","first-page":"e94788","DOI":"10.1371\/journal.pone.0094788","volume":"9","author":"J Kulkarni","year":"2014","unstructured":"Kulkarni J, Worsley R, Gilbert H, Gavrilidis E, Van Rheenen TE, Wang W, McCauley K, Fitzgerald P. A prospective cohort study of antipsychotic medications in pregnancy: the first 147 pregnancies and 100 one-year-old babies. PLoS One. 2014;9:e94788.","journal-title":"PLoS One"},{"key":"560_CR4","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4088\/JCP.v66n0406","volume":"66","author":"K McKenna","year":"2005","unstructured":"McKenna K, Koren G, Tetelbaum M, Wilton L, Shakir S, Diav-Citrin O, Levinson A, Zipursky RB, Einarson A. Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry. 2005;66:444\u20139 (quiz 546).","journal-title":"J Clin Psychiatry"},{"key":"560_CR5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1176\/appi.ajp.2015.15040506","volume":"173","author":"LS Cohen","year":"2016","unstructured":"Cohen LS, Viguera AC, McInerney KA, Freeman MP, Sosinsky AZ, Moustafa D, Marfurt SP, Kwiatkowski MA, Murphy SK, Farrell AM, Chitayat D, Hern\u00e1ndez-D\u00edaz S. Reproductive safety of second-generation antipsychotics: current data from the Massachusetts General Hospital National Pregnancy Registry for atypical antipsychotics. Am J Psychiatry. 2016;173:263\u201370.","journal-title":"Am J Psychiatry"},{"key":"560_CR6","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/jamapsychiatry.2016.1520","volume":"73","author":"KF Huybrechts","year":"2016","unstructured":"Huybrechts KF, Hern\u00e1ndez-D\u00edaz S, Patorno E, Desai RJ, Mogun H, Dejene SZ, Cohen JM, Panchaud A, Cohen L, Bateman BT. Antipsychotic use in pregnancy and the risk for congenital malformations. JAMA Psychiatry. 2016;73:938\u201346.","journal-title":"JAMA Psychiatry"},{"key":"560_CR7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/JCP.0b013e318172b8d5","volume":"28","author":"M Reis","year":"2008","unstructured":"Reis M, K\u00e4ll\u00e9n B. Maternal use of antipsychotics in early pregnancy and delivery outcome. J Clin Psychopharmacol. 2008;28:279\u201388.","journal-title":"J Clin Psychopharmacol"},{"key":"560_CR8","first-page":"35","volume":"11","author":"R Yamane","year":"2009","unstructured":"Yamane R, Hayashi M, Tanaka M, Hishinuma K, Ogawa K, Yokoo I, Kitagawa H. Survey regarding pregnant women receiving novel antipsychotic agents. Iyakuhin Johogaku. 2009;11:35\u20138.","journal-title":"Iyakuhin Johogaku"},{"key":"560_CR9","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1517\/14740338.2014.951325","volume":"13","author":"S Gentile","year":"2014","unstructured":"Gentile S. A safety evaluation of aripiprazole for treating schizophrenia during pregnancy and puerperium. Expert Opin Drug Saf. 2014;13:1733\u201342.","journal-title":"Expert Opin Drug Saf"},{"key":"560_CR10","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/JCP.0000000000000171","volume":"34","author":"E Windhager","year":"2014","unstructured":"Windhager E, Kim SW, Saria A, Zauner K, Amminger PG, Klier CM. Perinatal use of aripiprazole: plasma levels, placental transfer, and child outcome in 3 new cases. J Clin Psychopharmacol. 2014;34:637\u201341.","journal-title":"J Clin Psychopharmacol"},{"key":"560_CR11","doi-asserted-by":"crossref","first-page":"e1202","DOI":"10.1542\/peds.2009-3081","volume":"125","author":"KJ Gold","year":"2010","unstructured":"Gold KJ, Sen A, Hayward RA. Marriage and cohabitation outcomes after pregnancy loss. Pediatrics. 2010;125:e1202\u20137.","journal-title":"Pediatrics"},{"key":"560_CR12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2014.02.003","volume":"73","author":"MA Turner","year":"2014","unstructured":"Turner MA, Catapano M, Hirschfeld S, Giaquinto C. Paediatric drug development: the impact of evolving regulations. Adv Drug Deliv Rev. 2014;73:2\u201313.","journal-title":"Adv Drug Deliv Rev"},{"key":"560_CR13","doi-asserted-by":"crossref","first-page":"e0130399","DOI":"10.1371\/journal.pone.0130399","volume":"10","author":"S Bie de","year":"2015","unstructured":"de Bie S, Ferrajolo C, Straus SM, Verhamme KM, Bonhoeffer J, Wong IC, Sturkenboom MC. Pediatric drug safety surveillance in FDA-AERS: a description of adverse events from GRiP project. PLoS One. 2015;10:e0130399.","journal-title":"PLoS One"},{"key":"560_CR14","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3899\/jrheum.080545","volume":"36","author":"JD Carter","year":"2009","unstructured":"Carter JD, Ladhani A, Ricca LR, Valeriano J, Vasey FB. A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database. J Rheumatol. 2009;36:635\u201341.","journal-title":"J Rheumatol"},{"key":"560_CR15","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/apt.12936","volume":"40","author":"P Deepak","year":"2014","unstructured":"Deepak P, Stobaugh DJ. Maternal and foetal adverse events with tumour necrosis factor-alpha inhibitors in inflammatory bowel disease. Aliment Pharmacol Ther. 2014;40:1035\u201343.","journal-title":"Aliment Pharmacol Ther"},{"key":"560_CR16","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.2147\/DDDT.S81998","volume":"9","author":"K Nomura","year":"2015","unstructured":"Nomura K, Takahashi K, Hinomura Y, Kawaguchi G, Matsushita Y, Marui H, Anzai T, Hashiguchi M, Mochizuki M. Effect of database profile variation on drug safety assessment: an analysis of spontaneous adverse event reports of Japanese cases. Drug Des Devel Ther. 2015;9:3031\u201341.","journal-title":"Drug Des Devel Ther"},{"key":"560_CR17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1248\/yakushi.15-00235","volume":"136","author":"T Sakai","year":"2016","unstructured":"Sakai T, Ohtsu F, Sekiya Y, Mori C, Sakata H, Goto N. Methodology for estimating the risk of adverse drug reactions in pregnant women: analysis of the Japanese Adverse Drug Event Report database. Yakugaku Zasshi. 2016;136:499\u2013505.","journal-title":"Yakugaku Zasshi"},{"key":"560_CR18","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/pds.3749","volume":"24","author":"F Bellet","year":"2015","unstructured":"Bellet F, Beyens MN, Bernard N, Beghin D, Elefant E, Vial T. Exposure to aripiprazole during embryogenesis: a prospective multicenter cohort study. Pharmacoepidemiol Drug Saf. 2015;24:368\u201380.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"560_CR19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2177\/jsci.28.407","volume":"28","author":"R Kawaguchi","year":"2015","unstructured":"Kawaguchi R, Ozawa M, Ohta I, Suzuki M, Hayakawa S, Yamamoto T, Tanaka T. Prolactin (PRL) up-regulates indoleamine 2,3-dioxygenase (IDO) expression in CD14+ cells. Jpn J Clin Immunol. 2015;28:407\u201312.","journal-title":"Jpn J Clin Immunol"},{"key":"560_CR20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/JCP.0000000000000527","volume":"36","author":"R Sogawa","year":"2016","unstructured":"Sogawa R, Shimomura Y, Minami C, Maruo J, Kunitake Y, Mizoguchi Y, Kawashima T, Monji A, Hara H. Aripiprazole-associated hypoprolactinemia in the clinical setting. J Clin Psychopharmacol. 2016;36:385\u20137.","journal-title":"J Clin Psychopharmacol"},{"key":"560_CR21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3371\/CSRP.PRJA.022015","volume":"9","author":"AJ Propst","year":"2016","unstructured":"Propst AJ, Jarvis GE, Margolese HC. Aripiprazole-induced hypoprolactinemia in an adult male with first-episode psychosis. Clin Schizophr Relat Psychoses. 2016;9:173\u20136.","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"560_CR22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00737-013-0330-6","volume":"16","author":"S Toh","year":"2013","unstructured":"Toh S, Li Q, Cheetham TC, Cooper WO, Davis RL, Dublin S, Hammad TA, Li DK, Pawloski PA, Pinheiro SP, Raebel MA, Scott PE, Smith DH, Bobo WV, Lawrence JM, Dashevsky I, Haffenreffer K, Avalos LA, Andrade SE. Prevalence and trends in the use of antipsychotic medications during pregnancy in the US, 2001\u20132007: a population-based study of 585,615 deliveries. Arch Womens Ment Health. 2013;16:149\u201357.","journal-title":"Arch Womens Ment Health"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-017-0560-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-017-0560-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-017-0560-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T04:08:45Z","timestamp":1508213325000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-017-0560-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,29]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["560"],"URL":"https:\/\/doi.org\/10.1007\/s40264-017-0560-z","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,29]]}}}